Related Experiment Videos

The relationship of postprandial glucose to HbA1c

Rüdiger Landgraf1

  • 1Diabetes Center, Department of Internal Medicine Innenstadt, University of Munich, Germany. ruediger.landgraf@med.uni-muenchen.de

Insights

Understanding hemoglobin A1c (HbA1c) requires analyzing both fasting and postprandial glucose levels. Continuous glucose monitoring offers the best approach to clarify their relationship for optimal diabetes management.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Diabetes Management

Background:

  • Hemoglobin A1c (HbA1c) is the standard for assessing long-term glycemic control.
  • The precise contribution of fasting versus postprandial glucose to HbA1c remains unclear.
  • Postprandial glucose excursions are increasingly linked to micro- and macrovascular complications.

Purpose of the Study:

  • To investigate the relative importance of fasting and postprandial plasma glucose in determining HbA1c levels.
  • To inform therapeutic strategies for optimizing HbA1c and minimizing hypoglycemia.
  • To explore the relationship between different glucose measurements and HbA1c.

Main Methods:

  • Analysis of existing data on fasting and postprandial plasma glucose and HbA1c.
  • Exploration of correlations between various glucose measurements (premeal, postmeal, fasting) and HbA1c.
  • Highlighting the potential of continuous glucose monitoring (CGM).

Main Results:

  • HbA1c is difficult to predict from fasting plasma glucose alone.
  • A potential shift in contribution from postprandial to fasting glucose occurs at higher HbA1c levels.
  • Afternoon and evening glucose correlate better with HbA1c than morning values.

Conclusions:

  • Current data are inconclusive regarding the exact contribution of different glucose measures to HbA1c.
  • The definition and measurement of postprandial glucose present challenges.
  • Continuous glucose monitoring is essential for fully understanding the complex interplay between glucose profiles and HbA1c.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...